On Wednesday, February 12, CVS Health CVS will report its last quarter's earnings. Here is Benzinga's preview of the company's release.
Earnings and Revenue
Analysts expect CVS Health earnings of $1.68 per share. Revenue will likely be around $63.97 billion, according to the consensus estimate.
In the same quarter last year, CVS Health posted EPS of $2.14 on sales of $54.42 billion. If the company were to post earnings inline with the consensus estimate when it reports Wednesday, EPS would be down 21.50%. Revenue would be have grown 17.54% from the same quarter last year. Here's how the company's reported EPS has stacked up against analyst estimates in the past:
Quarter | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
EPS Estimate | 1.770 | 1.690 | 1.500 | 2.05 |
EPS Actual | 1.840 | 1.890 | 1.620 | 2.14 |
Stock Performance
Over the last 52-week period, shares are up 12.67%. Given that these returns are generally positive, long-term shareholders can relax going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.
Over the past 90 days, analysts have generally adjusted their estimates lower for EPS and revenues. The popular rating by analysts on CVS Health stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.
Conference Call
CVS Health is scheduled to hold a conference call at 8:00 a.m. ET and can be accessed here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.